Results 11 to 20 of about 211,280 (349)
Antiplatelet resistance in stroke [PDF]
Expert Review of Neurotherapeutics, 2011 Although the exact prevalence of antiplatelet resistance in ischemic stroke is not known, estimates about the two most widely used antiplatelet agents - aspirin and clopidogrel - suggest that the resistance rate is high, irrespective of the definition used and parameters measured. Inadequate antiplatelet responsiveness correlates with an increased risk
Ethem Murat Arsava +2 more
exaly +5 more sources
British Journal of Haematology, 2008 SummaryPlatelets play a major role in thromboembolic diseases, and so antiplatelet therapy remains crucial in treatment and prophylaxis. Upon vascular injury, platelets rapidly adhere to the exposed subendothelial matrix, after which they become activated, resulting in the recruitment of additional platelets from the circulation to eventually form a ...
Simon F, De Meyer +4 more
openaire +3 more sources
Sorghum Protein Extract Protects RBC from Sodium Nitrite-Induced Oxidative Stress and Exhibits Anticoagulant and Antiplatelet Activity [PDF]
Folia Medica, 2021 Introduction: Oxidative stress plays a critical role in the progression of diabetes, arthritis, cancer, eryptosis, cardiovascular disease, and thrombosis. Currently, antioxidants from natural sources are in high demand due to their beneficial role in the
Devaraja Sannaningaiah +10 more
doaj +3 more sources
A novel method of thrombelastograph analysis aids assessment of antiplatelet therapy in percutaneous coronary intervention. [PDF]
, 2010 MD (Research)Background A near-patient test of responses to antiplatelet therapy would be of great value in percutaneous coronary intervention (PCI). However, at present, there are no widely accepted tests and varied definitions of “resistance”.
Hobson, Alex
core +4 more sources
Российский кардиологический журнал, 2021 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment ...
J.-P. Collet +23 more
doaj +1 more source
Antithrombotic therapy after transcatheter aortic valve replacement
Heart Views, 2022 Transcatheter aortic valve replacement (TAVR) is a treatment option for patients with asymptomatic severe aortic stenosis who are candidates for a bioprosthesis across the entire spectrum of risk.
Tariq A.M. Mousa +2 more
doaj +1 more source
JAMA cardiology, 2022 Importance Clopidogrel monotherapy after short dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has not yet been fully investigated in patients with acute coronary syndrome (ACS).
Hirotoshi Watanabe +31 more
semanticscholar +1 more source
European Journal of Cardio-Thoracic Surgery, 2018 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS : The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the ...
M. Valgimigli +19 more
semanticscholar +3 more sources
Frontiers in Cardiovascular Medicine, 2021 Aims: In this pre-specified analysis of the “endothelium, stent and antiplatelet therapy” study, we investigate the impact of antiplatelet therapies on microvascular function in patients undergoing stenting for an acute coronary syndrome.Methods and ...
Boris Schnorbus +7 more
doaj +1 more source
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
New England Journal of Medicine, 2021 BACKGROUND The appropriate duration of dual antiplatelet therapy in patients at high risk for bleeding after the implantation of a drug-eluting coronary stent remains unclear.
M. Valgimigli +29 more
semanticscholar +1 more source